• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿拉巴马简易认知筛查量表:一种新型认知筛查工具在记忆障碍诊所的效用。

Alabama Brief Cognitive Screener: Utility of a New Cognitive Screening Instrument in a Memory Disorders Clinic.

作者信息

Love Marissa C Natelson, Pilonieta Giovanna, Geldmacher David S

机构信息

Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Department of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.

出版信息

Prim Care Companion CNS Disord. 2019 Mar 14;21(2):18m02336. doi: 10.4088/PCC.18m02336.

DOI:10.4088/PCC.18m02336
PMID:30896091
Abstract

OBJECTIVE

We assessed the clinical utility of the Alabama Brief Cognitive Screener (ABCs), an alternative to the Mini-Mental State Examination (MMSE), for cognitive screening in a new electronic medical record. Other available nonproprietary instruments were determined to be more tuned to milder deficits than the MMSE.

METHODS

The ABCs was administered as part of routine clinical assessment in the University of Alabama at Birmingham memory disorders clinics from April 30, 2012, to April 30, 2015. Outpatients (N = 1,589) with clinician diagnoses (ICD-9-CM) of memory loss, mild cognitive impairment, neurodegenerative cognitive impairment, Alzheimer's dementia, or dementia not otherwise specified were included in the analysis. Memory disorder clinicians used multiple sources of information for assignment of diagnoses, including interviews with patients and caregivers, the ABCs, figure copy, semantic fluencies, phonemic fluencies, ratings of daily function, imaging, laboratory tests, and medical records.

RESULTS

Scoring distribution by diagnosis was mild cognitive impairment (n = 310): mean (SD) = 25.47 (3.37), median = 26; Alzheimer's dementia (n = 208): mean (SD) = 16.42 (6.33), median = 17; cerebral degeneration (n = 371): mean (SD) = 20.61 (5.90), median = 21; memory loss (n = 583): mean (SD) = 24.90 (5.09), median = 27; and dementia (n = 117): mean (SD) = 15.18 (6.34), median = 15. Mean ABCs scores differed by diagnosis (Wilcoxon signed-ranks Z = 483.5, P < .001). This finding was consistent with a meta-analysis of MMSE performance between groups.

CONCLUSIONS

ABCs scores vary appropriately by diagnosis and resemble MMSE scoring distributions. The ABCs provides a nonproprietary alternative to the MMSE to assess the severity of cognitive deficits.

摘要

目的

我们评估了阿拉巴马简易认知筛查量表(ABCs)在新电子病历中用于认知筛查的临床效用,该量表可替代简易精神状态检查表(MMSE)。已确定其他现有的非专利工具比MMSE更适合检测较轻的认知缺陷。

方法

2012年4月30日至2015年4月30日期间,在阿拉巴马大学伯明翰分校记忆障碍诊所,ABCs作为常规临床评估的一部分进行施测。分析纳入了门诊患者(N = 1589例),这些患者经临床医生诊断(ICD-9-CM)患有失忆、轻度认知障碍、神经退行性认知障碍、阿尔茨海默病性痴呆或未另作说明的痴呆。记忆障碍临床医生使用多种信息来源进行诊断,包括与患者及照料者的访谈、ABCs、图形临摹、语义流畅性、语音流畅性、日常功能评分、影像学检查、实验室检查和病历。

结果

按诊断分类的得分分布为:轻度认知障碍(n = 310):均值(标准差)= 25.47(3.37),中位数 = 26;阿尔茨海默病性痴呆(n = 208):均值(标准差)= 16.42(6.33),中位数 = 17;脑变性(n = 371):均值(标准差)= 20.61(5.90),中位数 = 21;失忆(n = 583):均值(标准差)= 24.90(5.09),中位数 = 27;痴呆(n = 117):均值(标准差)= 15.18(6.34),中位数 = 15。ABCs的平均得分因诊断而异(Wilcoxon符号秩和检验Z = 483.5,P < .001)。这一发现与不同组间MMSE表现的荟萃分析结果一致。

结论

ABCs得分根据诊断情况有适当差异,且与MMSE得分分布相似。ABCs为评估认知缺陷的严重程度提供了一种非专利的MMSE替代方法。

相似文献

1
Alabama Brief Cognitive Screener: Utility of a New Cognitive Screening Instrument in a Memory Disorders Clinic.阿拉巴马简易认知筛查量表:一种新型认知筛查工具在记忆障碍诊所的效用。
Prim Care Companion CNS Disord. 2019 Mar 14;21(2):18m02336. doi: 10.4088/PCC.18m02336.
2
3
How Can We Best Screen for Cognitive Impairment in Malaysia? A Pilot of the IDEA Cognitive Screen and Picture-Based Memory Impairment Scale and Comparison of Criterion Validity with the Mini Mental State Examination.我们如何才能最好地在马来西亚筛查认知障碍?一项关于 IDEA 认知筛查和基于图片的记忆障碍量表的试点研究以及与简易精神状态检查表的效标效度比较。
Clin Gerontol. 2017 Jul-Sep;40(4):249-257. doi: 10.1080/07317115.2017.1311978. Epub 2017 Mar 29.
4
The Test Your Memory (TYM) Test Outperforms the MMSE in the Detection of MCI and Dementia.“测试你的记忆”(TYM)测试在检测轻度认知障碍(MCI)和痴呆症方面优于简易精神状态检查表(MMSE)。
Curr Alzheimer Res. 2017;14(6):598-607. doi: 10.2174/1567205013666161201202520.
5
The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.阿尔茨海默病型痴呆的画钟测试:记忆障碍门诊中三种评分方法的比较
Int J Geriatr Psychiatry. 1997 Jun;12(6):619-27.
6
Screening and case finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests.用于痴呆检测的筛查和病例发现工具。第一部分:多领域测试的基于证据的荟萃分析。
Am J Geriatr Psychiatry. 2010 Sep;18(9):759-82. doi: 10.1097/JGP.0b013e3181cdecb8.
7
The sensitivity and specificity of subjective memory complaints and the subjective memory rating scale, deterioration cognitive observee, mini-mental state examination, six-item screener and clock drawing test in dementia screening.主观记忆抱怨和主观记忆评定量表、认知观察者恶化、简易精神状态检查、六项筛查和时钟绘图测试在痴呆筛查中的敏感性和特异性。
Dement Geriatr Cogn Disord. 2013;36(1-2):119-35. doi: 10.1159/000350768. Epub 2013 Jul 12.
8
Validation of the Test Your Memory (F-TYM Test) in a French memory clinic population.《记忆自测(F-TYM测试)》在法国记忆诊所人群中的验证。
Clin Neuropsychol. 2014;28(6):994-1007. doi: 10.1080/13854046.2014.934716. Epub 2014 Aug 4.
9
Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?蒙特利尔认知评估量表(MoCA)的筛查效用:替代——还是补充——简易精神状态检查表(MMSE)?
Int Psychogeriatr. 2012 Mar;24(3):391-6. doi: 10.1017/S1041610211001839. Epub 2011 Oct 3.
10
Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).临床医生与护理人员在神经精神症状严重程度上的一致性:一项使用神经精神科问卷临床评定量表(NPI-C)的研究。
Int Psychogeriatr. 2014 Jul;26(7):1139-45. doi: 10.1017/S1041610214000295. Epub 2014 Mar 13.

引用本文的文献

1
The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults.美国成年人既往癌症诊断与全因痴呆进展的关系。
J Alzheimers Dis. 2022;88(2):521-535. doi: 10.3233/JAD-220054.
2
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.种族差异与阿尔茨海默病专家的相遇有关,与分子成像和痴呆症药物的使用有关:使用 i2b2 进行的全企业分析。
J Alzheimers Dis. 2021;79(2):543-557. doi: 10.3233/JAD-200796.